Antimicrobial properties of alpha-MSH and related synthetic melanocortins

A Catania1, G Colombo, C Rossi

  • 1Center for Preclinical Investigation, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano 20122, Italy. anna.catania@unimi.it

Thescientificworldjournal
|October 10, 2006
PubMed

Insights

Alpha-melanocyte stimulating hormone (alpha-MSH) exhibits antimicrobial activity against Staphylococcus aureus and Candida albicans. Its unique anti-inflammatory properties suggest potential for novel combination therapies.

Area of Science:

  • Biochemistry
  • Immunology
  • Microbiology

Background:

  • Natural antimicrobial peptides are ancient host defense molecules found across evolution.
  • Alpha-melanocyte stimulating hormone (alpha-MSH), a primordial peptide, shares characteristics with known antimicrobial molecules.
  • alpha-MSH is produced by various tissues, including epithelia, immunocytes, and the central nervous system.

Purpose of the Study:

  • To investigate the antimicrobial potential of alpha-melanocyte stimulating hormone (alpha-MSH).
  • To explore the mechanism of action of alpha-MSH against microbial pathogens.
  • To evaluate the unique properties of alpha-MSH in comparison to other antimicrobial peptides.

Main Methods:

  • Antimicrobial assays were performed using Staphylococcus aureus and Candida albicans.
  • Cellular cyclic adenosine monophosphate (cAMP) levels were measured to understand the mechanism of action.
  • Comparative analysis of alpha-MSH's properties with other natural antimicrobial molecules was conducted.

Main Results:

  • Alpha-MSH demonstrated antimicrobial activity against Staphylococcus aureus and Candida albicans.
  • The candidacidal effect of alpha-MSH was linked to increased intracellular cAMP levels.
  • This mechanism in yeast mirrors alpha-MSH's action in mammalian cells via melanocortin receptors.

Conclusions:

  • Alpha-MSH possesses significant antimicrobial properties.
  • Its mechanism of action involves modulating cAMP signaling pathways in microbes.
  • The anti-inflammatory and antipyretic effects of alpha-MSH offer unique therapeutic advantages.
  • Chemically stable derivatives of alpha-MSH could lead to novel anti-inflammatory and antimicrobial therapies.

Related Concept Videos

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...